Abstract
Percutaneous fistula creation may represent a new paradigm shift in dialysis access by allowing a minimally invasive approach that reduces surgical scarring and vessel trauma, creates a consistent side-to-side arteriovenous channel that decreases shear stress, and expands the available sites in the arm for fistula creation. In this single-center retrospective analysis of the clinical usability of the WavelinQ (Becton Dickinson, Covington, Ga) and Ellipsys (Avenu Medical, San Juan Capistrano, Calif) percutaneous arteriovenous fistula devices, the authors found that although a significant portion of patients met the instructions for use for creation using these technologies, only 55% met clinically relevant criteria for WavelinQ and 44% met criteria for Ellipsys.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call